Home » Newsletters » BioWorld Science

BioWorld Science

March 26, 2021

View Archived Issues

Benefit seen with tipifarnib in HRAS-mutant head and neck squamous cell carcinoma

Heartseed to initiate phase I/II LAPiS study of iPSC-derived cardiomyocyte spheroids

Data on weekly basal insulin LY-3209590 in patients with T2D presented

Vasomune provides preliminary phase I data for AV-001

GlaxoSmithKline initiates first-in-human study of GSK-4108771A

IMPACT Therapeutics synthesizes CHK1 inhibitors

Ono Pharmaceutical and Pharmaron Beijing patent DDR1 inhibitors

Chengdu Synowest Biotechnology discloses CDK inhibitors

Sunshine Lake Pharma presents new RET inhibitors

Enrollment ongoing in phase III study of LOXO-305 in MCL

New LECT2-targeting compounds identified by Alnylam Pharmaceuticals

Endocannabinoids act on astrocytes to prevent tremor

Safety and QoL data from phase III monarchE study of ET therapy with or without abemaciclib

DKN-01 demonstrates activity in gynecologic cancers with Wnt activating mutations

Japanese approval of Isturisa for endogenous Cushing's syndrome

RZ-358 shows promise for treating PGBH

Dual EBV oncoprotein targeting using upconversion nanomaterials for cancer monitoring and treatment

Multiple dosing of Lassa fever candidate LHF-535 well tolerated in healthy subjects

Depletion of DNA polymerase beta increases platinum sensitivity in epithelial ovarian cancers

FDA approves Myrbetriq tablets and granules for neurogenic detrusor overactivity in children

First-in-human data presented for SRP-9003 in patients with limb girdle muscular dystrophy type 2E

Sorrento reports further phase Ib data on COVI-MSC for COVID-19-induced ARDS

FDA accepts IND for phase Ib study of AT-100 for bronchopulmonary dysplasia

Chinese phase III trial of LY-03005 for major depressive disorder meets endpoints

Anaveon gains CTA clearance for phase I/II study of ANV-419 in advanced solid tumors

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...